Innovation
4 patent families (3 granted) — focus: Human necessities; filing pace accelerating. Cited 652 times.
| Year | Filings |
|---|---|
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |
Developing 5-HTP drugs to amplify serotonin for mental illness treatment
4 patent families (3 granted) — focus: Human necessities; filing pace accelerating. Cited 652 times.
| Year | Filings |
|---|---|
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |